Bifalgorithm post · Latest research · Statistical analysis

Study Models

Study Models (Latest research · Statistical analysis) — "This was an exploratory study. Five multivariable logistic regression models were constructed: three e…

Ideas in this flowchart

  • Exploratory study of associations among symptoms, PCC, and functional limitation
  • Five multivariable logistic regression models were constructed
  • Three models examined acute-phase symptoms and clinical or demographic characteristics in relation to PCC outcomes
  • PCC in Phase I
  • PCC in Phase II
  • Persistent PCC at Phase II among participants with PCC in Phase I
  • Two models examined persistent symptoms in relation to functional limitation
  • Functional limitation in Phase I
  • Functional limitation in Phase II
  • Associations between retrospectively reported acute-phase symptoms and PCC status were examined using cross-sectional analyses
  • Univariable and multivariable logistic regression analyses were performed separately for Phase I (2021) and Phase II (2024) cohorts
  • Acute-phase symptoms and PCC status were assessed retrospectively in the same survey in both phases
Feed/

Study Models

No cover

Channel

Latest research

1 page

"This was an exploratory study. Five multivariable logistic regression models were constructed: three examining associations of acute-phase symptoms and clinical or demographic characteristics with (1) PCC in Phase I, (2) PCC in Phase II, and (3) persistent PCC at Phase II among participants with PCC in Phase I, and two examining associations of persistent symptoms with functional limitation in (4) Phase I and (5) Phase II.\n\nTo examine associations between retrospectively reported acute-phase symptoms and PCC status, we performed cross-sectional univariable and multivariable logistic regression analyses separately for Phase I (2021) and Phase II (2024) cohorts. In both phases, acute-phase symptoms were assessed retrospectively in the same survey in which PCC status was determined."

Flowchart preview
👍
0
0 comments0 shares

Sign in to view and post comments.